Cargando…
Preclinical pharmacological profile of nomegestrol acetate, a synthetic 19-nor-progesterone derivative
BACKGROUND: Nomegestrol acetate (NOMAC), a synthetic progestogen derived from 19-nor-progesterone, recently completed clinical trials for use with 17beta-estradiol in a new monophasic combined oral contraceptive. In this review, published as well as previously unpublished preclinical studies that de...
Autor principal: | van Diepen, Harry A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571880/ https://www.ncbi.nlm.nih.gov/pubmed/23043680 http://dx.doi.org/10.1186/1477-7827-10-85 |
Ejemplares similares
-
Nomegestrol acetate-17b-estradiol for oral contraception
por: Burke, Anne
Publicado: (2013) -
Nomegestrol acetate/17-beta estradiol: a review of efficacy, safety, and patient acceptability
por: Akintomide, Hannat, et al.
Publicado: (2015) -
Nomegestrol acetate ameliorated adipose atrophy in a rat model of cisplatin‑induced cachexia
por: Zhong, Ruihua, et al.
Publicado: (2022) -
Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line
por: Li, Jie, et al.
Publicado: (2001) -
Potentially effective therapy of heavy menstrual bleeding with an oestradiol-nomegestrol acetate oral contraceptive: a pilot study
por: Weisberg, Edith, et al.
Publicado: (2017)